Neurovalens

Insomnia Relief with Neurostimulator Device – Modius Sleep

United Kingdom · $6.3M raised

Business Model
B2B
Total Funding
$6.3M
Last Round
$6.3M Series AMar 2019
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges. It uses neurostimulation therapy to address chronic insomnia and anxiety non-invasively. After a study of Modius Sleep for chronic insomnia, the company received FDA 510(k) clearance in October 2023, then FDA clearance for Modius Calm for anxiety in March 2024, with later FDA and EU/UK approvals for additional Modius devices including weight-management and PTSD indications. Modius is exclusively available to veterans through the U.S. Department of Veterans Affairs.

Summary

Neurovalens is a Healthcare company based in United Kingdom. It has raised $6.3M in total across 1 round, most recently a $6.3M Series A round in Mar 2019.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2019
$6.3M

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurovalens on Indexed.vc
<a href="https://indexed.vc/companies/neurovalens"><img src="https://indexed.vc/api/badge/company/neurovalens" alt="Neurovalens on Indexed.vc" width="260" height="76" /></a>